BioWorld

Feb. 6, 2004

View Archived Issues

XenoPort's Prodrug Efforts Yield $37M Equity Round

Read More

Biogen Idec, Celltech Team Up On CD40 Ligand Drugs

Read More

Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline

Read More

Correction

Read More

Anika Wins Orthovisc Approval After Long Development Road

Read More

Other News To Note

Read More

Renovis Prices $66M IPO; SGI, Exact Pull In Follow-On Funds

Renovis Inc. entered the public arena as the third biotech company to conduct an initial public offering this year, raising $66 million. (BioWorld Today) Read More